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Introduction: Shock is a life-threatening condition affecting about one third of pa-
tients in the ICU. The most common types of Shock are Septic and Cardiogenic,
affecting 62% and 16% of Shock patients, respectively. A rapid and specialized treat-
ment focused on the type of Shock is crucial for reducing its high mortality rate.
Unfortunately, current therapies strive to reduce the medical signs present by the
patients rather than target the cause of Shock. A better understanding of the mech-
anisms and pathophysiology of Shock is mandatory for improving its diagnosis.
Omic data and Machine Learning techniques make the perfect combination to tackle
this challenge.
Methodology: In this thesis, a two-step Machine Learning model has been pro-
posed for analysing proteomic data. The model consists of a Feature Selection method,
aimed at selecting relevant proteins, followed by a Classification method, whose
purpose is to predict the type of Shock. A robust procedure has been designed for
selecting the best model, i.e., stable, interpretable and accurate. Since there is no
consensus on the best stability measure, an analysis of different metrics has been
performed to decide which metric is more suitable for our problem.
Conclusions: Promising results have been obtained using the proteomic data
collected in the European research project ShockOmics from Septic and Cardiogenic
Shock patients. The best model, a combination of ReliefF and Random Forest, is ca-
pable of perfectly discriminate between these two types of Shock. On top of that, the
proposed model selected meaningful proteins which have been extensively studied
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Circulatory Shock, also known as Shock, is a life-threatening generalized form of
acute circulatory failure associated with inadequate oxygen utilization by the cells
[11]. In other words, the circulation in unable to deliver sufficient oxygen to sat-
isfy the tissues requirements, resulting in cellular injury and tissue malfunctioning.
Shock is a common condition in critical care, affecting about one third of patients in
the Intensive Care Unit (ICU) [71].
Depending on the underlying cause, Shock can be divided in four main types:
Hypovolemic Shock (HS), Cardiogenic Shock (CS), Obstrusive Shock (OS) and Distributive
Shock (DS). The last one can be further divided in Septic Shock (SS) , Anaphylactic
Shock (AS) and Neurogenic Shock (NS). SS is the most common form followed by
CS and HS, affecting 62%, 16% and 16% of Shock patients, respectively. The other
DS’s subtypes (Anaphylactic and Neurogenic) occur in 4% of Shock patients. OS is
relatively rare, affecting 2% of Shock patients [71].
The mortality rate of Shock is very high, especially for SS and CS. In Europe, it
ranges from 42% to 56% for SS [6, 55, 60, 62] and from 48% to 65% for CS [3, 26, 34,
54]. The incidence1 in the ICU ranges from 7% to 14% for SS and 6% to 9% for CS.
The support of patients in shock during the first hours is crucial. A rapid diag-
nosis and treatment is vital for avoiding permanent damage of the tissues. Indeed,
resuscitation should be started even while investigation of the cause is ongoing [71].
Nevertheless, establishing the diagnosis of SS and CS is not always easy. Sepsis, the
previous syndrome to SS, does not have a validated criterion standard diagnostic
test [63]. Even, patients hospitalized with CS occasionally develop SS [11]. Most
common CS is due to Acute Myocardial Infarction (AMI); however, the diagnosis of
CS and its cause is not always clear [66].
High-throughput technologies, producing vast amount of Omic data2, and Machine
Learning (ML) techniques, capable of analysing them, make the perfect combination
to tackle the challenge of rapid diagnosis of shock patients. This thesis is an step for-
ward to that direction.
1.1 Thesis Motivation
Many studies tried to typify Shock by analysing clinical variables through ML tech-
niques [70]. In fact, Shock’s types have heretofore been described using clinical
scores which rely on clinical variables. Current therapies strive to reduce the medical
1These data has been obtained from the same studies cited for the mortality rate.
2Referring to data coming from a biology field ending in -omics, i.e, genomics, proteomics,
metabolomics, transcriptomics ...
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signs of Shock, but they are unable to target its cause. Therefore, a better compre-
hension of the mechanisms and pathophysiology of Shock is necessary to reduce the
high mortality rate.
In the past decade, the volume of Omic data has expanded exponentially due
to the advances in biotechnology [56]. These data extensively characterize the be-
haviour of cells, tissues and organs at the molecular level which is key for under-
standing the aetiology of human diseases. Consequently, the analysis of Omic data
is essential for fathoming the underlying cause of Shock and, hence, improve its
diagnosis and prognosis.
ShockOmics3 was an European research project, which ended last year, aimed
at identifying molecular biomakers in acute heart failure induced by Shock. Omic
and hemodynamic data from CS, SS and HS patients were collected in a multicen-
ter prospective observational trial [5]. The two published findings were related to
the therapy of SS. Blood pressure variability, heart rate variability, and baroreflex
trends (hemodynamic variables) were studied for understanding the responsiveness
to therapy in the early phase of SS [10]. In [9], the authors provided evidence that
metabolic disturbances play an important role in individual patients’ responses to
infection.
The data analysed in this thesis is the ShockOmics’ proteomic dataset. The re-
searchers of the project analysed each type of Shock separately with the aim of de-
picting its responsiveness to early therapy 4. In contrast, this thesis focuses on char-
acterizing SS and CS through proteins.
1.2 Thesis Objectives
The aim of this thesis is to characterize SS and CS through proteomics data. In order
to achieve this aim, the objectives of this project are:
• Create a model capable of discriminating between SS and CS patients in
early stages using proteomic data. The diagnosis of the type of Shock is crucial
for providing the correct treatment.
• Analyse different stability metrics. Although the stability of the methods is
essential for creating a model capable of generalise to unseen data, there is no
consensus on the best stability measure.
• Identify key proteins for discriminating between SS and CS in early stages.
These proteins are fundamental for a better understanding of each type of
Shock.
1.3 Thesis Structure
This thesis is organized in six Chapters.
Chapter 2 provides the relevant background to understand the analysed data. It is
divided in two parts: Medical and Omic Background. In the former part, the
phathophysiological mechanisms, clinical signs and the type of Shock are ex-
plained, especially for SS and CS. Moreover, the two clinical scores most used
3http://www.shockomics.org/home
4https://cordis.europa.eu/result/rcn/213996_en.html
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in the ICU, Sequential Organ Failure Assessment (SOFA) and Acute Physiol-
ogy And Chronic Health Evaluation (APACHE) II, are defined. In the latter
part, Omic technologies and types of Omic data are explained, focusing on
Mass Spectrometry (MS) technique and proteomic data.
Chapter 3 reviews previous relevant studies in which MS data were analysed. Since
the disease or condition studied in the reviewed papers is not Shock, the focus
of this chapter is the methodology used rather than the results obtained.
Chapter 4 explains the methodology used for analysing proteomic data, including
the procedure for selecting the best model and an analysis of different stability
metrics. The proposed model consist on two steps: Feature Selection (FS) and
Classification (CLS). A brief introduction to each step is given followed by a
more detailed explanation of the experimented methods.
Chapter 5 presents the setting-up and the obtained results of both experiments,
analysis of stability metrics and proteomic data. A previous analysis of the
dataset is given at the beginning of the chapter, comparing the descriptive vari-
ables of the different populations and visualising the proteins’ intensities.
Chapter 6 concludes the thesis discussing the obtained results and presenting the





The aim of this chapter is to provided the necessary background to understand the
analysed data. Thus, the chapter is divided in two sections: Medical and Omic
Background. In the former section, Shock, especially SS and CS, are described. In
addition, the two main used Clinical Scores, SOFA and APACHE II, are detailed. In
the later section, Omic technologies and types of Omic data are explained, focusing
on MS technique and proteomic data.
2.1 Medical Background
The section 2.1.1 is in mainly based on the Consensus on Circulatory Shock [11].
2.1.1 Shock
Shock is a clinical state of acute circulatory failure that can result from one, or a
combination, of the following four pathophysiological mechanisms:
• decrease in venous return due to a loss of circulatory volume, i.e., internal or
external fluid loss;
• failure of the pump function of the heart that results from a loss of contractil-
ity, resulting from ischemia, infarction, myopathy or myocarditis; or a major
arrhythmia, such as ventricular tachycardia;
• obstruction due to a pulmonary embolism, tension pneumotorax or cardiac
tamponade;
• loss of vascular tone that results in maldistribution of blood flow, due to sepsis,
anaphylaxis or spinal injury.
These four mechanisms correspond to the four types of Shock enumerated in
Chapter 1. The three first types, HS, CS and OS, are characterized by low cardiac
output, whereas DS is associated with decreased peripheral resistance. Regarding
the oxygen, the former three types are featured by inadequate oxygen transport and
the latter type by altered oxygen extraction.
Shock is associated with evidence of inadequate tissue perfusion, clinical signs of
this alteration can be visualized through three windows:
• peripherial window: cold, clammy and blue skin
• renal window: low urine output
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• neurological window: altered mental characterized by obtundation, disorien-
tation and confusion.
Shock patients typically present arterial hypotension. Nevertheless, low blood
pressure is not a prerequisite for defining Shock, since Shock patients with chronic
hypertension could have moderate hypotension.
The clinical signs might vary depending on the type of Shock. DS is usually char-
acterized by an elevate cardiac output while the other types of shock are associated
with low cardiac output. HS patients present low blood pressures and volumes,
whereas these clinical signs are high in CS patients. OS is associated with increased
pulmonary artery pressure and dilated right sides cavities.
In the following sections SS and CS are explained in more detail. As mentioned
in Chapter 1, these two types of Shock have the worst prognosis among all the types
and are the ones studied in this work.
Septic Shock
SS is an advanced stage of Sepsis, which is a life-threatening organ dysfunction
caused by a dysregulated host [63]. Sepsis occurs when the body attacks its own
tissues and organs instead of the infecting pathogen. When Sepsis is aggravated
with persisting hypotension, it becomes SS. What differences sepsis from an infec-
tion is a dysregulated host response and the presence of organ dysfunction, i.e., the
organ does not perform its expected function.
The main origins of infection causing Sepsis, and, hence, SS are: respiratory,
manly lung infection; digestive, e.g., perforated viscus, ischemic bowel, cholecys-
titis, peritonitis, colitis; and urinary, e.g., pyelonephritis and obstructive uropathy
[4, 45].
SOFA score, which will be explained in detail in section 2.1.2, is used for clinically
characterize a Septic patient. The task force of [63] recommend using the difference
between the baseline and the currently SOFA score for identifying Sepsis, instead
of using the score value. More precisely, they suggest that a difference bigger than
two points indicates that the patient has Sepsis. The baseline SOFA score should
be assumed zero unless the patient is known to have preexisting origin dysfunction
before the onset infection.
Cardiogenic Shock
CS is a sever state of systemic hypoperfusion due to a cardiac dysfunction, often
followed by multiorganic failure [31]. It results from abnormalities of myocardial
structure and function, impairment of mechanical function of the heart or cardiac
dysrhythmia [66].
The main cause of CS is AMI, but can also be caused by, among others, Acute
Mitral Regurgitation, Ventricular Septal Rupture, Isolate Right Ventricular Failure.
APACHE II score, which will be explained in detail in section 2.1.2, correlates
with the mortality of patients with CS [38]. The value of this score, at the time of
admission, is significantly different between patients who survive from those who
do not. Specifically, patients with a APACHE II score higher than 31.5 are at sub-
stantially higher risk of death.
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2.1.2 Clinical Scores
The clinical scores main used in SS and CS, SOFA and APACHE II, are explained in
this section, highlighting their main objective and how they are measured/computed.
SOFA Score
SOFA score was created in a consensus meeting organized by European Society of
Intensive Medicine (ESICM) in 1994 [72]. At that time, the score was studied with
Sepsis patients and, consequently, named Sepsis-Related Organ Failure Assessment.
Nowadays, the score, renamed as Sequential Organ Failure Assessment, is broadly
used for organ failure assessment.
The main objective of the consensus was to describe quantitatively and as ob-
jectively as possible the degree of organ dysfunction/failure 1 over time in groups
of patients or even individuals. The authors pointed out that the score was meant
to describe a sequence of complication in the ICU patient, not only for predicting
mortality.
To make the score accessible to every institution, the evaluation of organ dysfunc-
tion/failure was based on simple variables, obtained through easily and routinely
measurements. Hence, the number of variables is limited to study six organs: res-
piratory, cardiovascular, coagulation, central nervous system, liver and renal. Other
important organs, such as the gut, are not included because of its complexity. For
each organ, its dysfunction/failure is assessed by ranging it from 0, meaning normal
function, to 4, meaning most abnormal function. More details of how to assess the
score for each organ can be found in [72].
APACHE II Score
APACHE II score was proposed by Knaus et al. [41] in 1985 for measuring severity of
acute disease. This score simplifies the previous version, APACHE [40], improving
its clinical usefulness.
The score was developed for objectively stratify acutely ill patients prognosti-
cally by risk of death. Thus, it can be viewed as a severity disease classification sys-
tem for evaluating the use of hospital resource or comparing the efficacy of intensive
care in different hospitals or over time.
The score is mainly computed by quantifying the degree of abnormality of vari-
ous routine physiologic measurements. The age of the patients and his/hers previ-
ous health status related severe organ system insufficiency and immunodeficiency
are also factored into the computation of the score. In particular, APACHE II mea-
sures 12 physiologic variables: temperature, mean arterial pressure, heart rate, res-
piratory rate, oxygenation, arterial pH, serum sodium, serum potassium, serum cre-
atine, percentage of hematocrits, white blood counts and Glasgow coma score. Each
of this variables is weighted depending of its importance. The final score it ranges
from 0 to 71, being 71 the worst prognostic.
2.2 Omic Background
Omic technologies utilise high-throughput screening techniques, which are able to
conduct millions of experiments simultaneously, to produce high quality data. These
1Organ failure is organ dysfunction to such a degree that normal homeostasis cannot be maintained
without external clinical intervention.
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technologies collect, transform and integrate Omic information. Before applying
ML techniques, the preprocessing of the data using Quality Assurance and Quality
Control techniques is advisable [39].
Omic experiments are data-driven, differing from more traditional biological
studies, which are hypothesis-driven [33]. In data-driven studies holistic approaches
are applied without any previous hypothesis to huge amounts of collected data, ob-
taining a hypothesis as a conclusion which should be further tested.
Omic data can be divided in four main types: genome, transciptome proteome
and metabolome. Each type represents the complete set of a specific type of molecule:
DNA, RNA, protein and metabolites, respectively. In the following section pro-
teome, the type of Omic data used in this thesis, is further explained.
2.2.1 Proteome
The proteome is the entire set of expressed proteins in a given type of cell or organ-
ism, at a given time and under defined conditions. The term was coined by Marc
Wilkins in 1994 [74]. Proteomics is the study of the proteome.
Proteins are large complex biomolecules, which perform a critical role within or-
ganisms, contributing to the structure, function and regulation of the tissues and or-
gans. Proteins are formed by long chains of amino acids combined in 3-dimensional
structures. They can be classified depending on their function: antibody, enzyme,
messenger, structural components and transport/storage.
There exist numerous technologies to extract quantitative proteins information
from biological samples: MS, two-dimensional gel electrophoresis, enzyme-linked,
immunosorbent assays, protein arrays and affinity separation. The proteomic data
analysed in this thesis were obtained by MS technique, thus this technique is exten-
sively explained in the next section.
2.2.2 Mass Spectrometry
MS is an analytic technique for the characterization of biological samples. The high-
throughput ability of this technique makes it suitable for large-scale proteomic pro-
filing, i.e., large lists of proteins are identified from samples that are analysed.
In particular, MS measures the mass-to-charge ratio (m/z) of molecules. In order
to be able to measure it, the molecules must first be electrically charged and changed
to gas phase. After that, their m/z ratios are measured by their movements through
an electric or magnetic field, this occurs in a mass analyser. Once measured, the
m/z values are visualised as mass spectra, which describes the molecules present
through peaks at the relevant m/z ratios [65].
Data from proteomic MS are typically characterized by very high-dimensional
feature spaces but relatively small numbers of samples. Therefore, before applying
any discriminative technique the dimensionality of the data must be reduced. Thus,
the most common ML pipeline applied on proteomic datasets obtained by MS con-




To the best of my knowledge there has not been any attempt to discriminate be-
tween SS and CS by analysing MS proteomic data through ML techniques. Never-
theless, proteomic data and ML techniques have been extensively used for studying
the prognosis and diagnosis of other diseases, e.g., cancer, rheumatoid arthritis, in-
flammatory bowel disease. The methodology applied in these studies is relevant
for this thesis since they used the same type of data. Thus, this chapter revises the
methodology of those studies in which MS proteomic data is analysed through ML
techniques, even though the target disease or condition is not Shock.
As mentioned in the previous chapter, a two-step model combining a FS method
followed by a CLS method is the most common ML pipeline used to analyse pro-
teomic data. Most studies combine different methods of each step to find the best
model. A great variety of FS methods has been used: filters and wrappers methods
[53, 73, 76], embedded methods [24] and biological based algorithms [46, 57]. Con-
trary to all these studies, in which the model contains just one CLS method, Bhanot
et al. [7] presented an interesting voting-based meta-classifier model combining the
prediction of multiple well-known classifiers: Artificial Neural Networks (ANN),
Support Vector Machine (SVM), K-Nearest Neighbour (KNN), Decision Tree (DT)
and Logistic Regression (LR). Table 3.1 summarises the details of these studies:
disease/condition, number of participants, FS and CLS methods experimented and
cross-validation procedure used.
New FS methods have been developed using Omic data. Recursive Feature Elim-
ination - Support Vector Machine (RFE-SVM), which is one of the most well-known
FS methods, was proposed in [29] for microarray data. Many variants of this method
have been used with proteomic data, e.g. [35, 79]. In [50, 30, 77], the authors pre-
sented a new method for reducing the high-dimensionality of proteomics data based
on Discrete Wavelet Transformation. However, dimensionality reduction techniques
are not advisable in Omic data due to the loss of interpretability [59].
All of the aforementioned studies used a cross-validation procedure, either k-
fold cross-validation or leave-one-out cross-validation, for validating its results. How-
ever, they do not specified if the FS method had been applied inside or outside the
validation procedure. As it is pointed out in [37], both steps of the pipeline, FS and
CLS, must be applied inside the validation procedure. Overestimated results would
be obtained if the FS method is applied over all the dataset, i.e., outside the cross-
validation procedure..
The stability of the FS method is crucial in Omic data due to their high dimen-
sionality [32]. An stable method is robust to small perturbation in data, i.e., the
selected features are not affect. However, only one of the above-mentioned studies
reported the stability of the FS method selected, [53]. The importance of reporting
the stability is highlighted in [36] by comparing different FS methods over various
datasets.











































































































































































































































































































































































































































































































































































































































Due to the lack of a standard methodology for analysing proteomic data found in
the literature, this work details a robust procedure for selecting the best model. The
focus has been put on stability of the selected features, since it is crucial for this
type of data. The proposed procedure has been experimented with state-of-the-art
methods.
4.1 Proteomic Data Analysis
Motivated by the related work explain in Chapter 3, the model proposed in this the-
sis for analysing proteomic data is a two-step ML pipeline combining a FS method
and a CLS method. The best model is defined by three characteristics: stability of the
FS method, performance of the CLS method and interpretability of the model. Since
there is no consensus on the best stability measure, an analysis of different stability
metrics has been performed to decide which metric is more suitable for our problem,
see section 4.2 for the details. Regarding the metric for measuring the CLS method’s
performance, since both classes are equally important and almost balanced, Accuracy
metric has been chosen for measuring the performance of the classifier.
For robustly selecting the best model, the data have been stratified randomly
split, with 70-30%, in two sets: training and testing set. The former set has been
used to select the best model; and the latter set to estimate the performance over
unseen data, once the best model has been chosen.
Regarding the selection of the best model, a stratified randomly sampling aimed
at selecting the most stable method has been nested in a 5-fold cross-validation pro-
cedure for selecting the classifier with the best Accuracy. To empirically estimate
the stability, the different FS methods have been fitted with small perturbations of
the original dataset. These new datasets have been obtained by randomly stratified
sampling the original dataset, using a 75% of the total amount of samples. This pro-
cedure has been done B = 100 runs. Hence, for each FS method 100 different subsets
has been used for estimating its stability by averaging the similarity of all the pairs of
features subsets (i.e., B(B− 1)/2 = 4950 pairs). Then, the best FS method has been
applied to the training set of the fold. The resulting dataset with the selected fea-
tures has been used to train the CLS methods and its performance has been reported
using the Accuracy over the validation set of that fold. Finally, the estimate of the
Accuracy for each model have been computed averaging the Accuracies among the
five folds. Once the best model has been selected its performance has been reported
over the testing set. Figure 4.1 summarises the proposed procedure.
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FIGURE 4.1: Diagram explaining the methodology used to select the
best model.
As highlighted in [36], choosing the FS method inside the cross-validation pro-
cedure decrease the bias of the results, due to the training set used for training the
classifier is the same used for selecting the more stable FS method.
4.2 Stability metrics analysis
As mentioned in the section 4.1, although there exist various metrics to assess the
stability of a FS method, there is no consensus on the best stability measure. These
metrics are mainly divided in three groups, depending on how the selected fea-
tures are reported: subset, ranking or weight/score. Some of the stability metrics
reviewed in [32] have been empirically compared in this thesis. In particular, four of
the ten stability metrics for subset of features and one of the three for raking features.
The weight/score metric has not been used because not all the proposed FS methods
for this work report scores. Moreover, as the authors pointed out this metric is the
less commonly used.
Regarding the subset metrics, the Length adjusted stability has been discarded be-
cause it uses a parameter which is not well defined and the default value, given in
the original paper [17] is not suitable for our dataset. From the other nine metrics,
there are several that are equivalent when comparing two sets with the same car-
dinality. In particular, Tanimoto distance is equivalent to Consistency; and Percentage
of overlapping features, Dice-Sorensen’s index, Ochiai’s index, Relative Hamming distance
and Weighted consistency are equivalent among them (see Appendix A for the mathe-
matical proof). Thus, the four subset metric empirically compared in this thesis are:
Tanimoto distance, Percentage of overlapping features, Percentage of overlapping features
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related and Kuncheva’s stability measure. Table 4.1 shows their formulation. All these
metrics take values in [0, 1], 1 indicates that both sets of features are identical and 0
indicates the sets are completely disjoint.
As regards the ranking features, only the Canberra distance has been used because
the other metrics take into account the whole dataset and we are only interested in
the best features. The smaller the Canberra distance, the more stable the method.
Table 4.1 shows how this metric is computed.
Metric Formulation
Tanimoto distance 1− |S|+ |S
′| − 2|S ∩ S′|
|S|+ |S′| − |S ∩ S′|
Percentage of overlapping features
|S ∩ S′|
|S|
Percentage of overlapping features related
|S ∩ S′|+ c
|S|
Kucheva’s stability measure






|min{R(i), k + 1} −min{R′(i), k + 1}|
min{R(i), k + 1}+ min{R′(i), k + 1}
c is the number of features in S that rare not in S’ but are significantly positively correlated with at least one feature in S’
m is the total number of features in the dataset
k is the number of features selected
TABLE 4.1: Stability metrics between two subsets of features (S and
S′) and Canberra distance between two rankings of features (R and
R′).
In order to decided which of the aforementioned metrics is more suitable for our
problem, the four subset metric, Tanimoto distance, Percentage of overlapping features,
Percentage of overlapping features related and Kuncheva’s stability measure and the Can-
berra distance have been empirically compared. All of them have been computed
following the stratified random sampling procedure explained in 4.1.
4.3 Methods
Five different methods have been experimented for each step of the pipeline. ReliefF,
Minimum Redundancy Maximum Relevance (mRMR), Weighted Principal Compo-
nent Analysis (WPCA), RFE-SVM and DT for the first step, FS. SVM, Random For-
est (RF), KNN, LR and Adaptative Boosting (AdaBoost) for the second one, CLS.
This section briefly describes both steps of the pipeline and the methods experi-
mented in each one. A more detailed explanation can be found in the cited original
paper of each method.
4.4 Feature Selection
MS technique for obtaining proteomic data produces large amounts of data. The
well-known curse of dimensionality would affect any classifier trained with all these
data. For avoiding this curse, the dimensionality of the data must be reduced. Di-
mensionality reduction techniques, such as those based on projection or compres-
sion, are not suitable because the original features are modified and the models are
no longer interpretable. Since FS methods do not alter the original representation
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of the features, but merely select a subset of them, they are more suitable when in-
terpretability is needed. In the literature, FS methods are usually divided in three
groups: filters, wrappers and embedded [28]. Filters methods assess the relevance of
features by looking only at the intrinsic properties of the data. These methods can
be further divided depending on how many features are taken into account for se-
lecting the best features: univariate and multivariate methods. Te goodness of the
selected features can be measured by different metrics, e.g., distance, information,
principal component. Wrappers methods use learning algorithms to evaluate dif-
ferent subsets of features according to their predictive power. Embedded methods
perform FS in the process of training a ML method. One method from each of these
categories have been experimented in this thesis.
Regarding filter methods, only multivariate techniques have been explored since
the complexity of diseases cannot be captured by a single protein [16]. Three filter
methods with different evaluation measures have been used: ReliefF (distance mea-
sure), mRMR (information measure) and WPCA (principal component measure).
ReliefF estimates the quality of features according to how well their values distin-
guish between instances that are near to each other. Given a sample, the algo-
rithm searches for its k nearest neighbours from the same class, called nearest
hits, and its k nearest neighbours from the other class, called nearest misses.
Then, the quality of each feature is updated by adding the distances between
the sample and each nearest miss and subtracting the distances between the
sample and each nearest hit. The key idea is that having a different value be-
tween the sample and its nearest hits (misses) means that this feature separates
two sample of the same (different) class which is bad (good). This procedure
can be done for all the sample (if there are small number of sample) or for a
group of randomly selected samples. [58].
mRMR is a twofold procedure consisting of maximizing the relevance and the min-
imizing the redundancy of the selected features. Both concepts are computed
by using Mutual Information (MI), which measures the level of similarity. The
relevance, defined as the importance of a feature, is computed by measuring
the level of discriminant power, i.e., measuring MI between the feature and
the class. The redundancy is computed as the similarity between features. The
first step of the algorithm selects a feature with maximum relevance. Then, the
rest of the features are incrementally selected using the following criterion: the
selected feature is the one with the maximum relevance and the minimum re-
dundancy among the previously selected features. This criterion can be com-
bined in just one optimization problem by maximizing the difference or the
quotient of the these quantities,relevance and redundancy. Although there ex-
ist methods for computing MI on continuous data, better results are reported
in the original paper using the discrete version of MI on discretized continu-
ous data. The data is discretized by mean± t ∗ std where t is a threshold which
normally takes the following values 0.5, 1 and 2 [19].
WPCA is based on the principal component weights as a measure of the feature
importance. The number of Principal Component (PC) to use can be select
by the user or it can be used as many features as needed to have at least 90%
of the information present in the data. The weights of the selected PC are
used to compute the Global Importance (GI) of each feature; together with
the importance of the component and the discriminant power of the feature.
The first step of the algorithm chooses the feature with higher GI. Then, for
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choosing the following features the GI of all the remaining features is updated
with the correlation between the selected feature and the remaining ones. The
feature with the highest GI is selected [14].
The well-known wrapper method for gene selection RFE-SVM has been experi-
mented. Although the method was develop for selecting genes on microarray data,
it is also suitable for other Omic data, such as MS proteomic data.
RFE-SVM recursively eliminates the less important features according to the weights
of SVM. Firstly, a Linear SVM is trained using the whole set of features. Then,
the features are ranked by using the weights assigned to them by the classifier.
The last important features are eliminated, in this step just one or a set of fea-
tures can be removed. The procedure is repeated until the required number of
features to select is reached [29].
As an embedded method a forest of DT has been used. After training a forest of
trees and importance score for each feature can be calculated an used as a FS method.
DT are grown to its maximum depth when they are used as FS method. At each
node, a given number of features are randomly choose. Then, the samples
are split by randomly choosing a value from the range of values of the chosen
feature [25]. The score of importance of a given feature is the increasing in
mean of the error of a tree in the forest when the observed values of this feature
are randomly permuted in the Out-of-bag (OOB) samples [23].
4.5 Classification
As most of the problems in Omic data, our main objective is to classify binary la-
belled samples, i.e., we are dealing with a binary supervised classification prob-
lem. There exist many ML methods for tackle this kind of problem. In this work,
five state-of-the-art classifiers have been experimented: SVM, RF, KNN, LR and
AdaBoost. Since all these methods are conceptually different, their complexity and
interpretability are different. Although complex methods have good predictive re-
sults, they usually suffer from overfitting. Interpretability can be defined as the abil-
ity to understand the rationale behind a obtained results by a model. Among these
five classifiers, the most complex is SVM and the most interpretable is RF [42].
SVM conceptually classifies the samples by using a hyperplane. When the training
set is not perfectly separable, the regularization parameter, C, determines the
weight of the misclassified samples. The shape of the hyperplane is defined
by a kernel, which could be, among others, linear or Gaussian, also known as
Radial Basis Function (RBF). With RBF kernel, the parameter γ can be used to
define the influence of the training samples [13].
RF is an averaging ensemble learning method, which builds several independent
estimators and then averages their predictions. Each of these estimators is a
decision tree, which learns simple decision rules inferred from the features.
The size of the random subset of features considered when splitting a node
can be delimited by fixing its maximum number of features in the subset [68].
KNN is a simple algorithm that uses the k closest training samples in the feature
space to predict the class of a new given sample. Distance between samples
is calculated using the Euclidean distance. For a given sample, its predicted
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class is the most common one among its neighbours’ classes. A weight can
be added to the contributions of the neighbours, so that the contribution of
the samples is proportional to the distance from the given one. The number
of neighbours (k) should be a positive integer. In binary classification, when
the neighbours contribute with the same weight, k should be an odd number,
avoiding possible ties [15].
LR tries to model the posterior probabilities of the class belonging to a particular
category. These probabilities are modelled by using a logistic function. De-
spite its name, its is a linear method for classification. The penalty in the cost
function can be done by using either L1-norm or L2-norm. The regularization
parameter, C, works as in SVM, smaller values specify stronger regularization
[22].
AdaBoost is an adaptive version of the boost by majority algorithm. It sequentially
combines a bunch learning algorithms, called weaker learners, into a proper
method, called strong learner. For the first weak learner, all the samples have
the same weights. For the following learners, the weights of incorrectly clas-
sified examples are increased so that the weak learner is forced to focus on
the hard examples in the training set. The final strong learner is a weighted




This chapter starts with an overview of the dataset used in the experiments. Then,
the setting up and the results of both experiments analysis of stability metrics and
the proteomics data analysis, has been reported.
5.1 Dataset
As mentioned before, the data used in this work comes from the European research
project ShockOmics, where several data sources were collected. More details of the
different sources can be found in [5]. Among these sources, human blood sam-
ples were collected and pre-processed for Omics analysis. This thesis is focussed
on analysing the proteomic data.
More specifically, the blood samples were collected from 48 ICU patients: 29
Université de Genève (Hôpitaux Universitaires de Genève) (UNIGE) and 19 from
Université Libre de Bruxelles (Hôpital Erasme) (ULB). The collecting last from Octo-
ber 2014 to March 2016 and during this period a total number of three blood samples
were acquired:
• T1: acute response shock (16h after ICU admission)
• T2: steady-state after administration of therapy against the onset shock (48h
after ICU admission)
• T3: steady-state of relevant system level consequences (7 days before ICU ad-
mission or before ICU discharge or before discontinuing therapy (death))
Samples from T1 point were collected before the therapy has taken effect, when
the Shock has already activated the main pathophysiological cascades of inflamma-
tion and disease. Moreover, as stated before the objective of this thesis is to identify
the type of Shock in early stages because a rapid diagnosis during the first hours
of the Shock is of paramount importance for avoiding permanent damage of the
tissues. Therefore, only T1 data have been used in this study.
As the data come from patients of two different ICU, it is sensible to check if there
are any significant differences in the main descriptive variables of the two popula-
tions. Table 5.1 shows the sex, ICU outcome, i.e., alive or dead, the age of the patient
when he/she was admitted in the ICU, the SOFA score at T1, the APACHE II Score
at T1, the number of affected organs and number of days at the ICU. All these vari-
ables have been computed for the patients grouped by ICU and by type of Shock, as
well as, for all the patients.
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All UNIGE ULB SS SC
n 48 29 19 28 20
Sex (Male) 35 23 12 19 16
ICU Outcome (Alive) 39 27 12 23 16
Age 65.71± 17.15 67.55± 16.57 62.89± 18.08 66.21± 20.01 65.00± 12.57
SOFA 11.75± 2.70 12.14± 2.62 11.16± 2.79 11.82± 2.71 11.65± 2.76
APACHE II 24.17± 7.03 24.83± 6.52 23.16± 7.81 23.75± 6.58 24.75± 7.75
Affected Organs 4± 0.90 3.95± 0.94 4.05± 0.85 4.07± 0.90 3.9± 0.91
Days in ICU 8.13± 5.80 7.62± 5.62 8.89± 6.14 8.61± 6.06 7.45± 5.50
TABLE 5.1: Descriptive variables of five populations: whole group of
patients, those coming from the Hôpitaux Universitaires de Genève,
Université de Genève (UNIGE), those from the Hôpital Erasme, Uni-
versité Libre de Bruxelles (ULB), those who has Cardiogenic Shock
(CS) and those with Septic Shock (SS). The categorical variables are
reported using the number of samples of the category in parenthesis.
The continuous variables are reported with its mean and standard
deviation
The Mann-Whitney U test has been used for assessing if the continues variables
have significant differences between the populations of ICU (UNIGE and ULB) and
the population of type of Shock (SS and CS). The null hypothesis of this test is
that the two independent samples were selected from populations having the same
distribution. As shown in Table 5.2, there are not significant differences between the




APACHE II 0.190137 0.307372
Affected organs 0.403328 0.207085
Days in ICU 0.194995 0.380074
TABLE 5.2: Results (p-values) from the Mann-Whitney U test for
assessing if the continuous variables have significant differences
between the populations of UCI (the Hôpitaux Universitaires de
Genève, Université de Genève (UNIGE) and Hôpital Erasme, Uni-
versité Libre de Bruxelles (ULB)) and between the population of type
of shock (Septic Shock (SS) and Cardiogenic Shock (CS)).
The proteomic data consist of 261 different labelled proteins obtained by MS.
These data were already preprocessed by ShockOmics researchers, so the ML tech-
niques can be applied without further biological processing. Figure 5.1 shows the
intensities of all proteins, y-axis, for each patient, x-axis. The patients have been
divided by type of Shock and by ICU. In general, the proteins intensities of the SS
patients are higher than those of the CS patients, which indicates that the type of
shock could be characterized using these proteins. Regarding differences between
the samples coming from different ICU, the proteins intensities of the UNIGE’s pa-
tients are a little bit higher than those of the ULB’s patients, especially for the SS
patients.
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FIGURE 5.1: Heatmap representing the intensities of the proteins for
each patient. Each vertical line represents a patients and each hori-
zontal line represents a protein. The patients have been divided by
type of Shock (i.e., Cardiogenic and Septic Shock) and by ICU (i.e.,
UNIGE: Hôpitaux Universitaires de Genève, Université de Genève
and ULB: Hôpital Erasme, Université Libre de Bruxelles)
To sum up, the dataset has 48 samples for 261 features. Since the data have more
features than samples, the experiments performed must ensure the generalization
of the estimated result. Performing a features selection step before applying the
classifier will prevent the classifier from suffering the curse of dimensionality.
5.2 Stability metrics analysis
5.2.1 Setting up
The four subset metric, Tanimoto distance, Percentage of overlapping features, Percentage
of overlapping features related and Kuncheva’s stability measure and the Canberra distance
have been empirically compared over the five FS methods, ReliefF, mRMR, WPCA,
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RFE-SVM and DT. The default value of its hyper-parameters has been used ex-
cept for the number of features to select, for which the following values has been
experimented 2, 3, 4, 5, 10, 15, 20. Table 5.3 shows the default values of the other
hyper-parameter.
Method Parameter Range
ReliefF Number neighbours 10
DT Number estimators 10
mRMR
Discretization threshold 1
Method Mutual Information Difference
RFE-SVM C of SVM estimator 10
TABLE 5.3: Default hyper-parameters for Feature Selection methods
used in the stability analysis.
5.2.2 Results
The comparison among the subset metrics is reported using line charts, which are
suitable for comparing different trends. In this comparison, the specific number ob-
tained by each metric is not relevant, what is important is to compare the behaviour
of the stability among metrics. Figure 5.2 shows the comparison among the four
metrics: Tanimoto distance (on the top left), overlapping percentage (on the top right),
related overlapping percentage (on the bottom left) and Kuncheva measure (on the bot-
tom right). The x-axis of each chart represents the number of selected features and
each line correspond to one FS method. As shown in the Figure 5.2, the four metrics
have similar behaviour among the five FS methods. In other words, given a number
of features to be select and ordering the five FS methods by its stability, the same
ranking is obtained for all the metrics. Therefore, one of these four metrics can be
used as a representation of the subset metric. We will use Tanimoto distance, since it
is the most well-known among the four metrics and it is used in [36].
A bar chart has been used to better compare the results obtained by the Tanimoto
distance and the Canberra distance among the five FS methods for a given number of
feature to be select. Figure 5.3 shows the results of the Tanimoto distance for each
of the five FS methods, each method represented by a different colour. The x-axis
represents the number of selected features. The results shows that ReliefF is most
stable for all the number of selected features, but for selecting 3 features. In this
case, the WPCA method is more stable, by 0.049. This method is the second more
stable when selecting 2 and 4 features, but its stability decrease considerably when
selecting 5, 10, 15 and 20. For these subsets of features the DT method is the sec-
ond more stable, and it is almost as stable as the ReliefF method when selecting 10
features.
Figure 5.4 shows the results of the Canberra distance for each of the five FS meth-
ods, each method represented by a different colour. The x-axis represents the num-
ber of selected features. Recall that the smaller the Canberra distance the more stable
the method. These results show that ReliefF method is the most stable method for all
the different number of selected features. In this case, when 3 features are selected,
the instability value of WPCA is higher than ReliefF by 0.0624 and when 10 features
are selected, ReliefF is much more stable than DT.
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FIGURE 5.2: Comparison between different stabilities metrics for fea-
tures subsets. Each metric is display in a different plot: Tanimoto
distance (on the top left), overlapping percentage (on the top right), re-
lated overlapping percentage (on the bottom left) and Kuncheva measure
(on the bottom right). Each line correspond to one Feature Selection
method. The stability has been computed for the following number
of selected features: 2, 3, 4, 5, 10, 15, 20.
FIGURE 5.3: Results of the Tanimoto distance for each of the five Fea-
ture Selection methods and for the following number of selected fea-
tures: 2, 3, 4, 5, 10, 15, 20.
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FIGURE 5.4: Results of the Canberra distance for each of the five Fea-
ture Selection methods and for the following number of selected fea-
tures: 2, 3, 4, 5, 10, 15, 20.
Tanimoto distance and Canberra distance are not directly comparable, since the
scales are completely different. The former metric ranges from 0 to 1 and the lat-
ter metric takes values in the positives. For comparing its results the methods will
be ranked from more to less stable. Figure 5.5 shows the comparison between the
stability ranking of the FS methods for each feature to be selected. As shown in Fig-
ure 5.5, both rankings are equal when selecting 2 features and completely different
except for the first position when selecting 20 features. In the other cases only two
position of the rankings are interchanged. Focusing on the position through differ-
ent numbers of features to be selected, both metrics coincide in the first position of
the ranking all the times but one, four times for the second and third position, only
two times in the fourth and five times in the last position. Thus, there are no big
differences in the selected method for both metrics.
Since both metrics have similar results and in the pipeline the CLS method is
applied over all the selected subset, i.e., the order in which the features was been
selected is not important, Tanimoto distance has been used for estimating the stability
in the nested cross-validation procedure.
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FIGURE 5.5: Comparison of Tanimoto distance and Canberra distance.
For each feature to be selected the position in the stability ranking of
the different methods has been compared.
5.3 Proteomic Data Analysis
5.3.1 Setting up
As a conclusion of the section 5.2, the metric chosen for estimating the stability of
the FS methods in the nested cross-validation procedure is Tanimoto distance. The
performance of the CLS method has been measured by Accuracy. For each method,
different values of its hyper-parameters have been experimented, Table 5.4 shows
them.
Method Parameter Range
ReliefF Number neighbours 3, 5, 7, 9, 11, 13
DT Number estimators 5, 8, 11, 14, 17, 20, 23, 26, 29, 32, 35, 38, 41, 44, 47
mRMR
Discretization threshold 0.5, 1, 2
Method Mutual Information Quotient, Mutual Information Difference
RFE-SVM C of SVM estimator 0.01, 0.1, 1, 10, 100, 1000, 10000
SVM
kernel Linear, RBF
C 0.01, 0.1, 1, 10, 100, 1000, 10000
γ (RBF) 0.0001, 0.001, 0.01, 0.1, 1, 10, 100, 1000
RF
Number estimators 5, 8, 11, 14, 17, 20, 23, 26, 29, 32, 35, 38, 41, 44, 47
Maximum features From 1 to maximum of features
KNN
Number neighbours 3, 5, 7, 9, 11, 13
Weight Uniform, Distance
LR
C 0.01, 0.1, 1, 10, 100, 1000, 10000
Penalty L1, L2
AdaBoost Number estimators 25, 28, 31, 34, 37, 40, 43, 46, 49, 52, 55, 58, 61, 64, 67, 70, 73
TABLE 5.4: Range of each hyper-parameter.
Since the number of sample in the testing set is limited, just 15 samples, the
results obtained could be biased from the true generalization error. Permutation test
has been used to validate if the obtained results are due to chance. Therefore, the
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best model has been retrained 100 times permuting the values of the class. The p-
value obtained with this procedure represents the fraction of randomized samples
where the model behaves better in random data than in the original data [51].
As in the feature selection experiments, different numbers of features to be se-
lected has been explored. Thus, a total of seven models have been created, each one
with a different number of features to be selected: 2, 3, 4, 5, 10, 15 and 20. From now
one, each experiment will be called Exp-x, where x represent the number of features
to be selected.
5.3.2 Results
ReliefF has been selected in all the experiments as the most stable method. Table 5.5









TABLE 5.5: Relief average stability over the five folds for each exper-
iment.
For each experiment, Table 5.6 shows, the cross-validation results, reporting the
best accuracy obtained by each family of classifiers and the percentage of configura-
tions which obtained this performance. The results obtained are very high, almost
all above the 0.95. As shown, at least one SVM configuration is capable of classify-
ing perfectly all the samples of the validation sets, except in Exp-20. This result is
expected since complex method have good predictive power, especially when the
number of features is small. RF and LR results are also great, obtaining a perfect
classification in all the experiments but in two, in Exp-2 and Exp-4 for RF and in
Exp-2 and Exp-3 for LR. In these cases the performance is also good, being Accuracy
= 0.97± 0.06. KNN, the simplest method, is not able to make a perfect classification,
though its results are good. AdaBoost obtained the same result for all the configura-
tion, ranging from Accuracy = 0.94± 0.11 to the perfect classification depending on
the number of features to be selected.
SVM RF KNN LR AdaBoost
Exp-2 1.00± 0.00 (7.94) 0.97± 0.06 (100.00) 0.97± 0.06 (25.00) 0.97± 0.06 (92.86) 0.97± 0.06 (100.00)
Exp-3 1.00± 0.00 (15.87) 1.00± 0.00 (86.67) 0.94± 0.07 (100.00) 0.97± 0.06 (7.14) 0.97± 0.06 (100.00)
Exp-4 1.00± 0.00 ( 7.94) 0.97± 0.06 (86.67) 0.97± 0.06 (50.00) 1.00± 0.00 (7.14) 1.00± 0.00 (100.00)
Exp-5 1.00± 0.00 (7.94) 1.00± 0.00 (95.00) 0.97± 0.06 (50.00) 1.00± 0.00 (50.00) 1.00± 0.00 (100.00)
Exp-10 1.00± 0.00 (22.22) 1.00± 0.00 (58.52) 0.97± 0.06 (16.67) 1.00± 0.00 (35.71) 0.97± 0.06 (100.00)
Exp-15 1.00± 0.00 (23.81) 1.00± 0.00 (63.33) 0.94± 0.07 (100.00) 1.00± 0.00 (21.43) 1.00± 0.00 (100.00)
Exp-20 0.97± 0.06 (25.40) 1.00± 0.00 (58.95) 0.94± 0.07 (100.00) 1.00± 0.00 (21.43) 0.94± 0.11 (100.00)
TABLE 5.6: Best CV-Accuracy for each experiment. The percentage
of Configurations with this performance has been reported, between
parentheses
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Since the interpretability is key in this work and the most interpretable family
of classifiers, RF, obtained promising results, we will focus on this family. For each
experiment, the less complex configuration from the ones which obtained higher CV-
Accuracy has been evaluated over the testing set. The complexity of the RF method
is measured by the number of estimators and the maximum features. The higher the
number values of those parameters, the higher the complexity.
Table 5.7 shows the best configuration for each experiment an its Accuracy over
the testing set. The ReliefF’s hyper-parameter is the number of neighbours and the
RF’s hyper-parameter are the number of estimators and the maximum features. All
the models perfectly classifies the testing set. The complete list of configurations
which achieved the best CV-results can be found in the Appendix B, Tables B.1, B.2,
B.3, B.4, B.5, B.6, B.7.
Best Model Test Accuracy
Relief RF
Exp-2 11 5, 1 1.00
Exp-3 5 8, 1 1.00
Exp-4 5 8, 3 1.00
Exp-5 7 5, 2 1.00
Exp-10 11 17, 4 1.00
Exp-15 13 5, 1 1.00
Exp-20 9 5, 2 1.00
TABLE 5.7: Testing results of the best configuration for each exper-
iment. The ReliefF’s hyper-parameter is the number of neighbours.
The RF’s hyper-parameter are the number of estimators and the max-
imum features.
Figure 5.6 shows the permutation test result for validating the Accuracy obtained
over the testing set in each experiment. As shown, the p-values are smaller than 0.05
in all the cases and the results obtained by permuting the target values are less than
0.85. Thus, the results obtained over the testing set are not obtained by chance.
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FIGURE 5.6: Permutation test results of the best model for each ex-
periment.
Table 5.8 shows the features selected in each experiment by the best model, Reli-
efF. All the proteins selected in an experiment have also been selected in the exper-
iments with larger number of features to select. The only exception is the protein
Q15582, which is selected in the experiment Exp-15 but not in the Exp-20.
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Exp-2 Exp-3 Exp-4 Exp-5 Exp-10 Exp-15 Exp-20
P05160 P05160 P05160 P05160 P05160 P05160 P05160
P03952 P03952 P03952 P03952 P03952 P03952 P03952
P43652 P43652 P43652 P43652 P43652 P43652
P03951 P03951 P03951 P03951 P03951
















TABLE 5.8: Proteins for the best model in each experiment.
Figure 5.7 shows the five selected features in the Exp-5 using the heatmap in
which the intensities of the proteins are plotted for each patient. Figures C.1, C.2,
C.3, C.4, C.5 and C.6, in the Appendix C, show the heatmap highlighting the se-
lected features in Exp-2, Exp-3, Exp-4, Exp-10, Exp-15 and Exp-20, respectively. The
selected features show a clear pattern: the intensities of these proteins are higher for
SS patients than for CS patients.
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FIGURE 5.7: Heatmap representing the intensities of the proteins, y-





A two-step ML model has been proposed for analysing proteomic data. In the first
step a FS method aimed at selecting relevant proteins and in the seconds a CLS
method, whose purpose is to predict the type of Shock. The best model has been
obtained by maximizing the stability of the FS method and the predictive power of
the CLS method in a nested validation procedure. The interpretability has also been
factored into choosing the best model.
Different stability metrics have been analysed to choose the most suitable one
for our problem. Five stability metrics, four subset metrics and one raking metric,
have been empirically compared through five FS methods and different numbers
of features to be select, 2, 3, 4, 5, 10, 15, 20. All the subset metrics analysed have an
equivalent behaviour. Moreover, no big differences has been found between Tan-
imoto distance (subset metric) and Canberra distance (ranking metric). In fact, both
metrics choose ReliefF as the most stable method in all the cases, except for selecting
3 features. In this case, Tanimoto distance selects WPCA as the most stable method
followed by ReliefF. Nevertheless, the difference between the stability of these two
methods is 0.049.
Seven different models have been created, each one with a different number of
features to be selected, 2, 3, 4, 5, 10, 15, 20. The best model obtained in all the ex-
periments is composed by ReliefF and RF. For all the experiments, the best model
perfectly classifies the testing set. Permutation test with p-values smaller than 0.05
ensure that the results obtained over that testing set are not obtained by change.
Although these results are encouraging, the main limitation of this study is the
limited size of the population. Only samples from 48 patients, 28 with CS and 20
with SS has been analysed. On top of that, the testing set only contains 15 samples,
9 with CS and 6 with SS. Therefore, we should focus on the proteins selected for
obtaining these results rather than the prediction performance per se.
The selected proteins are coherent through the different experiments, meaning
that all the proteins selected in an experiment have also been selected in the exper-
iments with larger number of features to select. The only exception is the protein
Q15582, which is selected in the experiment Exp-15 but not in the Exp-20. The levels
of the selected proteins are higher for SS patients than for CS patients. Table 6.1 con-
tains the description of all the selected proteins ordered by experiment, meaning the
two first proteins where selected for the Exp-2, the three first for Exp-3, and so forth.
Several studies relating most of the selected features with SS can be found in the
literature: Coagulation factor XIII B chain [8, 67, 75, 78], Plasma kallikrein, [1, 48, 62],
Afamin [44], Coagulation factor XI [18, 69, 64], Kininogen-1 [44], Alpha-1B-glycoprotein
[43], Complement C5 [12, 49], Insulin-like growth factor-binding protein 3 [2, 27, 47, 52]
and Selenoprotein P [20, 21, 80]. Most of these papers analyse the behaviour of the
protein comparing survival versus non-survival of SS patients or SS patients versus
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controls. In [48], the authors also point out that Plasma kallikrein does not play a role
in CS.
Identifier Protein Description
P05160 Coagulation factor XIII B chain
P03952 Plasma kallikrein
P43652 Afamin
P03951 Coagulation factor XI
P01042 Kininogen-1
P54108 Cysteine-rich secretory protein 3
P04217 Alpha-1B-glycoprotein
P00748 Coagulation factor XII
P05155 Plasma protease C1 inhibitor
Q92954 Proteoglycan 4
P01031 Complement C5
P11597 Cholesteryl ester transfer protein
P17936 Insulin-like growth factor-binding protein 3
P08253 72 kDa type IV collagenase
Q15582 Transforming growth factor-beta-induced protein ig-h3
Q9UHG3 Prenylcysteine oxidase 1
P49908 Selenoprotein P
P05154 Plasma serine protease inhibitor
P22891 Vitamin K-dependent protein Z
P02753 Retinol-binding protein 4
P02766 Transthyretin
TABLE 6.1: Description of the selected proteins ordered by experi-
ment, meaning the two first proteins where selected for the Exp-2, the
three first for Exp-3, and so forth.
To further validate the results obtained in this thesis two main future lines are
proposed. Firstly, the models should be applied over other datasets to validate its
capability of generalisation to unseen data. Secondly, the validation of the selected
features can be assess by comparing the features selected for models trained over
different datasets. Another interesting future line is to amplify the analysis of the
stability metrics by comparing more FS methods and using other datasets.
It is worth mentioning that the methodology presented in this thesis is general
i.e. it does not assume any particularity of the proteomic data, further than its high
dimensionality. Therefore, it can be used not only for analysing proteomic data but




This appendix is intended to proof that several subset metrics reviewed in [17] are
equivalent when comparing two sets with the same cardinality. In particular, Tani-
moto distance is equivalent to Consistency; and Percentage of overlapping features, Dice-
Sorensen’s index, Ochiai’s index, Relative Hamming distance and Weighted consistency are
equivalent among them. Table A.1 shows the formulation of these metrics.
Metric Formulation
Tanimoto distance 1− |S|+ |S
′| − 2|S ∩ S′|






f req( f )− 1










Relative Hamming distance 1− |S \ S




f req( f )
|S|+ |S′| · f req( f )− 1
f req( f ) denotes the number of occurrences of feature f in {S, S′}
* in [17] the sum is divided by the number of compared subset minus 1, in our case the denominator is reduced to 1, thus it is omitted
TABLE A.1: Stability metrics between two subsets of features (S and
S′).
In order to prove these equalities we will use the well-known property of cardi-
nalities between sets given in Lemma 1
Lemma 1.
|S ∪ S′| = |S|+ |S′| − |S ∩ S′|
Proof.
S∪ S′ can be break up in three different disjoint sets, S∪ S′ = (S \ S′)∪ (S \ S′)∪
(S ∩ S′), as is shown in Figure A.1.
Then, using the property that the cardinality of a disjoint union is the sum of its
cardinalities, we obtain:
|S ∪ S′| = |S \ S′|+ |S \ S′|+ |S ∩ S′|
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S′ \ SS \ S′ S ∩ S′
FIGURE A.1: Union of sets S, green circle, and S’, red circle.
As shown in Figure A.1, S = (S \ S′) ∪ (S ∩ S′) and S′ = (S′ \ S) ∪ (S ∩ S′). The
cardinality of S and S′ can be computed using again the property of cardinality of
disjoint sets:
|S| = |S \ S′|+ |S ∩ S′|
|S′| = |S′ \ S|+ |S ∩ S′|
Now, substituting |S \ S′| and |S′ \ S| in the first formula, the desired formula is
obtained:
|S ∪ S′| = |S \ S′|+ |S \ S′|+ |S ∩ S′|
= |S| − |S ∩ S′|+ |S′| − |S′ \ S|+ |S ∩ S′|+ |S ∩ S′|
= |S|+ |S′| − |S ∩ S′|
The following proposition proves that Tanimoto distance is equivalent to Consis-
tency when they are computed for two sets.
Proposition 1.
Tanimoto distance is equivalent to Consistency when they are computed for two sets.
Proof.
Let be S and S two sets.
Then, Tanimoto distance can be directly simplified as:
1− |S|+ |S
′| − 2|S ∩ S′|
|S|+ |S′| − |S ∩ S′| =
|S ∩ S′|
|S|+ |S′| − |S ∩ S′|
Regarding Consistency metric, its term f req( f ) is equal to 2 if f ∈ S ∩ S′ and 1





f req( f )− 1









Then, for Lemma 1 Tanimoto distance and Consistency are equals
In the following propositions, we will pair-wisely prove that Relative Hamming
distance, Dice-Sorensen’s index, Ochiai’s index and Percentage of overlapping features are
equivalent.
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Proposition 2.
Dice-Sorensen’s index is equivalent to Percentage of overlapping features when comparing
two sets with the same cardinality.
Proof.
Let be S and S′ two sets of the same cardinality, i.e., |S| = |S′|.









Ochiai’s index is equivalent to Percentage of overlapping features when comparing two sets
with the same cardinality.
Proof.
Let be S and S′ two sets of the same cardinality, i.e., |S| = |S′|.










Relative Hamming distance is equivalent to Dice-Sorensen’s index when comparing two sets.
Proof.
Using the fact that |S ∪ S′| = |S \ S′| + |S \ S′| + |S ∩ S′|, seen in the proof of
Lemma 1, Relative Hamming distance can be rewritten as:
1− |S \ S
′|+ |S′ \ S|
|S|+ |S′| = 1−
|S ∪ S′| − |S ∩ S′|
|S|+ |S′|
This formula can be further simplified by using Lemma 1 :
1− |S ∪ S
′| − |S ∩ S′|
|S|+ |S′| =




The simplification obtained is indeed the Dice-Sorensen’s index.
Proposition 5.
Weighted consistency is equivalent to Dice-Sorensen’s index when comparing two sets with
the same cardinality.
Proof.
As the denominator is not affected by the summatory, Weighted consistency can
be rewritten as follows:
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∑
f∈{S,S′}
f req( f )





f req( f )2 − f req( f )

Then, the Weighted consistency can be simplified, using the fact that when two





f req( f )2 − f req( f )













The complete list of configurations which achieved the best CV-results for the exper-
iments Exp-2, Exp-3, Exp-4, Exp-5, Exp-10, Exp-15 and Exp-20 are shown in Tables B.1,
B.2,B.3,B.4,B.5,B.6 and B.7, respectively. All the list are ordered from less complex to
more complex configurations.
















TABLE B.1: RF configurations which obtain the best CV-Accuracy for
selecting 2 features.
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TABLE B.2: RF configurations which obtain the best CV-Accuracy for
selecting 3 features.
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TABLE B.3: RF configurations which obtain the best CV-Accuracy for
selecting 4 features.
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Number estimators Maximum features Number estimators Maximum features
5 2 29 1
5 2 29 2
5 3 29 3
5 4 29 4
8 1 32 1
11 1 32 2
11 2 32 3
11 3 32 4
11 4 35 1
14 1 35 2
14 2 35 3
14 3 35 4
14 4 38 1
17 1 38 2
17 2 38 3
17 3 38 4
17 4 41 1
20 1 41 2
20 2 41 3
20 3 41 4
20 4 44 1
23 1 44 2
23 3 44 3
23 4 44 4
23 5 47 1
26 1 47 2
26 2 47 3
26 3 47 4
26 4
TABLE B.4: RF configurations which obtain the best CV-Accuracy for
selecting 5 features.
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Number estimators Maximum features Number estimators Maximum features
17 4 35 3
17 5 35 4
17 6 35 5
17 7 35 6
17 8 35 7
17 9 35 8
23 3 35 9
23 4 38 1
23 5 38 2
23 6 38 3
23 7 38 4
23 8 38 5
23 9 38 6
26 1 38 7
26 3 38 8
26 4 38 9
26 5 41 1
26 6 41 2
26 7 41 3
26 8 41 4
26 9 41 5
29 1 41 6
29 3 41 7
29 4 41 8
29 5 41 9
29 6 44 4
29 7 44 5
29 8 44 6
29 9 44 7
32 1 44 8
32 2 44 9
32 3 47 2
32 4 47 3
32 5 47 4
32 6 47 5
32 7 47 6
32 8 47 7
32 9 47 8
35 1 47 9
35 2
TABLE B.5: RF configurations which obtain the best CV-Accuracy for
selecting 10 features.
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Number estimators Maximum features Number estimators Maximum features Number estimators Maximum features
5 1 17 3 26 6
5 2 17 4 26 7
5 3 17 5 26 8
5 4 17 6 26 9
5 5 17 7 26 10
5 6 17 8 26 11
5 7 17 9 26 12
5 8 17 10 26 13
5 9 17 11 26 14
5 10 17 12 29 1
5 11 17 13 29 2
5 12 17 14 29 3
5 13 20 1 29 4
5 14 20 2 29 5
8 1 20 3 29 6
11 1 20 4 29 7
11 2 20 5 29 8
11 3 20 6 29 9
11 4 20 7 29 10
11 5 20 8 29 11
11 6 20 9 29 12
11 7 20 10 29 13
11 8 20 11 29 14
11 9 20 12 32 1
11 10 20 13 32 2
11 11 20 14 32 3
11 12 23 1 32 4
11 13 23 2 32 5
11 14 23 3 32 6
14 1 23 4 32 7
14 2 23 5 32 8
14 3 23 6 32 9
14 4 23 7 32 10
14 5 23 8 32 11
14 6 23 9 32 12
14 7 23 10 32 13
14 8 23 11 32 14
14 9 23 12 35 1
14 10 23 13 35 2
14 11 23 14 35 3
14 12 26 1 38 1
14 13 26 2 38 2
14 14 26 3 38 3
17 1 26 4
17 2 26 5
TABLE B.6: RF configurations which obtain the best CV-Accuracy for
selecting 15 features.
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Number estimators Maximum features Number estimators Maximum features Number estimators Maximum features
5 2 17 7 26 13
5 3 17 8 26 14
5 4 17 9 26 15
5 5 17 10 26 16
5 6 17 11 26 17
5 7 17 12 26 18
5 8 17 13 26 19
5 9 17 14 29 3
5 10 17 15 29 4
5 11 17 16 29 5
5 12 17 17 29 6
5 13 17 18 29 7
5 14 17 19 29 8
5 15 20 3 29 9
5 16 20 4 29 10
5 17 20 5 29 11
5 18 20 6 29 12
5 19 20 7 29 13
11 3 20 8 29 14
11 4 20 9 29 15
11 5 20 10 29 16
11 6 20 11 29 17
11 7 20 12 29 18
11 8 20 13 29 19
11 9 20 14 32 4
11 10 20 15 32 5
11 11 20 16 32 6
11 12 20 17 32 7
11 13 20 18 32 8
11 14 20 19 32 9
11 15 23 3 32 10
11 16 23 4 32 11
11 17 23 5 32 12
11 18 23 6 32 13
11 19 23 7 32 14
14 3 23 8 32 15
14 4 23 9 32 16
14 5 23 10 32 17
14 6 23 11 32 18
14 7 23 12 32 19
14 8 23 13 35 4
14 9 23 14 35 5
14 10 23 15 35 6
14 11 23 16 35 7
14 12 23 17 35 8
14 13 23 18 35 9
14 14 23 19 35 10
14 15 26 4 35 11
14 16 26 5 35 12
14 17 26 6 35 13
14 18 26 7 35 14
14 19 26 8 35 15
17 3 26 9 35 16
17 4 26 10 35 17
17 5 26 11 35 18
17 6 26 12 35 19






Figures C.1, C.2, C.3, C.4, C.5 and C.6 show the selected features in experiments Exp-
2, Exp-3, Exp-4, Exp-5, Exp-10, Exp-15 and Exp-20, respectively. The selected features
are highlighted in heatmaps representing the intensities of the proteins, y-axis, for
each patient, x-axis.
FIGURE C.1: Heatmap representing the intensities of the proteins, y-
axis, for each patient, x-axis. The selected proteins in Exp-2 are high-
lighted
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FIGURE C.2: Heatmap representing the intensities of the proteins, y-
axis, for each patient, y-axis. The selected proteins in Exp-3 are high-
lighted
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FIGURE C.3: Heatmap representing the intensities of the proteins, y-
axis, for each patient, x-axis. The selected proteins in Exp-4 are high-
lighted
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FIGURE C.4: Heatmap representing the intensities of the proteins, y-
axis, for each patient, x-axis. The selected proteins in Exp-10 are high-
lighted.
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FIGURE C.5: Heatmap representing the intensities of the proteins, y-
axis, for each patient, x-axis. The selected proteins in Exp-15 are high-
lighted.
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FIGURE C.6: Heatmap representing the intensities of the proteins, y-
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